24 LIfesciences trend

 According to a newly published market research report by 24LifeSciences , global piezoelectric extracorporeal shock wave therapy device market was valued at USD 806 million in 2024 and is projected to reach USD 1,095 million by 2031 , growing at a compound annual growth rate (CAGR) of 4.5% during the forecast period 2024-2031 . Piezoelectric extracorporeal shock wave therapy (ESWT) devices are advanced medical instruments that utilize the piezoelectric effect to generate high-energy acoustic waves for non-invasive treatment of musculoskeletal disorders. These devices are clinically proven for conditions like plantar fasciitis , tendinopathies , and calcific shoulder tendonitis , offering advantages such as minimal downtime and reduced risk of complications compared to surgical alternatives. The technology stimulates tissue regeneration and improves blood circulation through precisely targeted acoustic pulses. Download a Free Sample Report (PDF): https://www.24lifesciences.com/...

  According to a newly published market research report by 24LifeSciences , global myocardial infarction treatment market was valued at USD 190 million in 2024 and is projected to reach USD 272 million by 2031 , growing at a compound annual growth rate (CAGR) of 5.4% during the forecast period 20252031 . Myocardial infarction, commonly known as heart attack, requires immediate medical intervention to restore blood flow to the heart muscle. Treatment protocols combine pharmacological interventions (antiplatelets, anticoagulants, thrombolytics) with procedural therapies (PCI, CABG), representing a critical segment in cardiovascular care with growing importance due to rising CVD prevalence worldwide. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/15816/myocardial-infarction-treatment-market Global Cardiovascular Disease Burden Drives Treatment Demand The myocardial infarction treatment market growth is primarily fueled by the rising global pre...

 According to a newly published market research report by 24LifeSciences , global myocardial infarction treatment market was valued at USD 190 million in 2024 and is projected to reach USD 272 million by 2031 , growing at a compound annual growth rate (CAGR) of 5.4% during the forecast period 20252031 . Myocardial infarction, commonly known as heart attack, requires immediate medical intervention to restore blood flow to the heart muscle. Treatment protocols combine pharmacological interventions (antiplatelets, anticoagulants, thrombolytics) with procedural therapies (PCI, CABG), representing a critical segment in cardiovascular care with growing importance due to rising CVD prevalence worldwide. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/15816/myocardial-infarction-treatment-market Global Cardiovascular Disease Burden Drives Treatment Demand The myocardial infarction treatment market growth is primarily fueled by the rising global prev...

 According to a newly published market research report by 24LifeSciences , global UltraPure Sterile Water market was valued at USD 8.2 billion in 2025 and is projected to reach USD 12.9 billion by 2034 , growing at a compound annual growth rate (CAGR) of 5.8% during the forecast period 20262034 . UltraPure Sterile Water (UPSW) is a critical component in pharmaceutical manufacturing and semiconductor production, undergoing advanced purification processes including reverse osmosis, electrodeionization, and UV treatment to achieve exceptionally low levels of contaminants. Meeting strict pharmacopeia standards, it contains <1 ppb total organic carbon and <0.1 EU/ml endotoxins, making it indispensable for sensitive applications where even trace impurities can cause catastrophic failures. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/15330/ultrapure-sterile-water-market Semiconductor Industry Expansion and Pharmaceutical Quality Standards D...

 According to a newly published market research report by 24LifeSciences , the global botulinum toxins market was valued at USD 7.21 billion in 2024 and is projected to reach USD 13.02 billion by 2031 , growing at a compound annual growth rate (CAGR) of 8.9% during the forecast period 20252031 . Botulinum toxin, derived from the bacterium Clostridium botulinum , is a potent neurotoxic protein that temporarily inhibits acetylcholine release at neuromuscular junctions, causing muscle relaxation or paralysis. While infamous for causing botulism, its highly purified pharmaceutical formulations have become indispensable in both aesthetic medicine and therapeutic applications . The market is primarily driven by the exponential growth in cosmetic procedures and expanding FDA approvals for medical indications, with North America dominating global revenue. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/7214/botulinum-toxins-market Rising Demand for ...

  According to a newly published market research report by 24LifeSciences , global Marfan Syndrome treatment market was valued at USD 112 million in 2025 and is projected to reach USD 187 million by 2034 , growing at a compound annual growth rate (CAGR) of 5.8% during the forecast period 20262034 . Marfan Syndrome is a rare genetic disorder affecting connective tissue, primarily impacting the cardiovascular, ocular, and skeletal systems . Current treatment modalities focus on symptom management and prevention of life-threatening complications , including beta-blockers, angiotensin receptor blockers (ARBs), and complex surgical interventions for aortic root dilation and valve pathologies. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/15225/marfan-syndrome-treatment-market Growing Disease Awareness and Diagnostic Capabilities Drive Market Expansion The increasing recognition of Marfan Syndrome among healthcare professionals and improved geneti...

  According to a newly published market research report by 24LifeSciences , global breast cancer treatment market was valued at USD 26.5 billion in 2024 and is projected to reach USD 42.8 billion by 2031 , growing at a compound annual growth rate (CAGR) of 7.1% during the forecast period 20252031 . Breast cancer treatment encompasses multiple therapeutic approaches designed to eliminate malignant cells in breast tissue, including chemotherapy, radiation therapy, biologic targeted therapy, breast surgery, and hormone therapy . These treatments are tailored based on cancer stage, tumor biology, and patient factors, with significant advances in personalized medicine driving market transformation. The field has evolved from one-size-fits-all approaches to precision oncology, where treatments are increasingly biomarker-driven. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/15570/breast-cancer-treatment-market Rising Global Breast Cancer Incidence ...

  According to a newly published market research report by 24LifeSciences , the global cardiotonic agents market was valued at USD 1.85 billion in 2025 and is projected to reach USD 2.67 billion by 2034 , growing at a compound annual growth rate (CAGR) of 4.3% during the forecast period 20262034 . Cardiotonic agents are pharmacological substances that enhance cardiac contractility and improve heart function. These medications play a crucial role in managing heart failure, cardiac arrhythmias, and cardiogenic shock . The market primarily includes digitalis glycosides, phosphodiesterase inhibitors, cardioprotectants, and sympathomimetic agents , each working through distinct mechanisms to support cardiovascular function. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/15453/cardiotonic-agents-market Growing Cardiovascular Disease Burden Drives Market Expansion The increasing global incidence of cardiovascular diseases (CVDs) remains the primar...

  According to a newly published market research report by 24LifeSciences , global licorice extract products market was valued at USD 1.5 billion in 2025 and is projected to reach USD 2.4 billion by 2034 , growing at a compound annual growth rate (CAGR) of 5.2% during the forecast period 20262034 . Licorice extract, derived from Glycyrrhiza glabra roots, contains bioactive compounds including glycyrrhizin, flavonoids, and polysaccharides that provide medicinal and functional properties. These extracts serve as natural sweeteners, flavor enhancers, and therapeutic agents across pharmaceuticals (for anti-inflammatory and hepatoprotective effects), food & beverages (for natural sweetening), and cosmetics (for skin-brightening properties). The extract comes in pharmaceutical, food, and feed grades, meeting diverse industry requirements. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/15168/licorice-extract-products-market Growing Demand for ...

  According to a newly published market research report by 24LifeSciences , global aprepitant injection market was valued at USD 450 million in 2024 and is projected to reach USD 880 million by 2032 , growing at a compound annual growth rate (CAGR) of 7.1% during the forecast period 2025-2032 . Aprepitant Injection, clinically known as a neurokinin-1 (NK1) receptor antagonist , is a critical submicron emulsion formulation widely used for preventing chemotherapy-induced nausea and vomiting (CINV) in cancer patients. Its unique intravenous delivery system offers enhanced bioavailability and reduced allergic reactions compared to oral formulations, making it particularly valuable for patients with gastrointestinal intolerance or swallowing difficulties. The drug's established efficacy in both acute and delayed-phase CINV continues to solidify its position in oncology supportive care protocols. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/140...

 According to a newly published market research report by 24LifeSciences , the Global Darbepoetin Alfa Market was valued at USD 4.34 Billion in 2024 and is projected to reach USD 3.52 Billion by 2031 , declining at a compound annual growth rate (CAGR) of -3.0% during the forecast period 20252031 . Darbepoetin Alfa, a hyperglycosylated analog of recombinant human erythropoietin marketed under brands like Aranesp and Nespo , is a long-acting erythropoiesis-stimulating agent (ESA) . Its engineered structure provides a significantly longer half-life than earlier ESAs, reducing dosing frequency for patients. It is a vital therapeutic for managing anemia associated with chronic kidney disease (CKD) , both in dialysis and non-dialysis patients, and for treating chemotherapy-induced anemia in cancer patients. Its established role in stimulating red blood cell production continues to make it a cornerstone of supportive care in nephrology and oncology. Download a Free Sample Report (PDF...